Select Publications
Aapro M et al. Guidance on the use of bisphosphonates in solid tumours: Recommendations of an international expert panel. Ann Oncol 2008;19(3):420-32. Abstract
Brufsky AM. Bone health issues in women with early-stage breast cancer receiving aromatase inhibitors. Curr Oncol Rep 2008;10(1):18-26. Abstract
Coleman RE. Risks and benefits of bisphosphonates. Br J Cancer 2008;98(11):1736-40. Abstract
Fidler IJ. Seed and soil revisited: Contribution of the organ microenvironment to cancer metastasis. Surg Oncol Clin N Am 2001;10(2):257-69, vii-viiii. Abstract
Fokas E et al. Metastasis: The seed and soil theory gains identity. Cancer Metastasis Rev 2007;26(3-4):705-15. Abstract
Gnant M et al. Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-responsive, stage I and II breast cancer: First efficacy results from ABCSG- 12. Proc ASCO 2008;Abstract LBA4.
Gnant M et al. Zoledronic acid effectively counteracts cancer treatment induced bone loss (CTIBL) in premenopausal breast cancer patients receiving adjuvant endocrine treatment with goserelin plus anastrozole versus goserelin plus tamoxifen — Bone density subprotocol results of a randomized multicenter trial (ABCSG-12). San Antonio Breast Cancer Symposium 2004;Abstract 6. No Abstract Available.
Ingle J et al. NCIC CTG MA.17: Intent to treat analysis (ITT) of randomized patients after a median follow-up of 54 months. Proc ASCO 2006;Abstract 549.
Kostenuik PJ. Revisiting the seed and soil theory of bone metastasis: New tools, same answer. J Musculoskelet Neuronal Interact 2004;4(4):375-6. No abstract available
Marx RE et al. Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007;65(12):2397-410. Abstract
Phadke PA et al. Kinetics of metastatic breast cancer cell trafficking in bone. Clin Cancer Res 2006;12(5):1431-40. Abstract
Piris A, Mihm MC Jr. Mechanisms of metastasis: Seed and soil. Cancer Treat Res 2007;135:119-27. No abstract available
Ripamonti CI et al. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol. 2008 Jul 22 [Epub ahead of print]. Abstract
EDITOR'S NOTE
Austrian tag team
Neil Love, MD
- Select publications
INTERVIEWS
Michael Gnant, MD
- Select publications
Hyman B Muss, MD
- Select publications
Matthew J Ellis, MB, BChir, PhD
- Select publications
Charles L Vogel, MD (Fellows Rounds)
- Select publications
Breast Cancer Update:
A CME Audio Series and Activity